Brown Brothers Harriman & CO Catalent, Inc. Transaction History

Brown Brothers Harriman & CO

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$42.56 - $59.82 $1,915 - $2,691	-45 Reduced 11.9%	333 $18,000
Q4 2023 Feb 12, 2024	BUY	$32.18 - $46.57 $1,448 - $2,095	45 Added 13.51%	378 $16,000
Q2 2023 Aug 07, 2023	SELL	$31.86 - $67.26 $127 - $269	-4 Reduced 1.19%	333 $14,000
Q1 2023 May 11, 2023	BUY	$45.44 - $74.26 $181 - $297	4 Added 1.2%	337 $22,000
Q4 2022 Feb 09, 2023	SELL	$41.39 - $81.0 $12,168 - $23,814	-294 Reduced 46.89%	333 $14,000
Q3 2022 Nov 10, 2022	BUY	$72.36 - $113.1 $15,485 - $24,203	214 Added 51.82%	627 $45,000
Q2 2022 Aug 11, 2022	BUY	$87.2 - $114.05 $4,272 - $5,588	49 Added 13.46%	413 $44,000
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $2,490 - $3,055	29 Added 8.66%	364 $38,000
Q2 2020 Aug 13, 2020	BUY	$48.02 - $79.04 $96 - $158	2 Added 0.6%	335 $25,000
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $2,211 - $2,662	-47 Reduced 12.37%	333 $19,000
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $353 - $487	9 Added 2.43%	380 $21,000
Q1 2019 May 15, 2019	BUY	$29.84 - $43.92 $11,070 - $16,294	371 New	371 $15,000
Q1 2018 May 14, 2018	SELL	$39.4 - $47.39 $1,812 - $2,179	-46 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $1,714 - $1,978	46	46 $2,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

Stay updated on Brown Brothers Harriman & CO with notifications on news.